Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Slowly releasing allopurinol tablet and its prepn

A technology of sustained-release tablet and allopurinol, which is applied in the field of allopurinol sustained-release tablet and its preparation, can solve the problems such as the inability to maintain anti-gout blood drug concentration, and achieve the effect of stable and effective blood drug concentration

Active Publication Date: 2006-03-01
HAINAN PULIN PHARMA +1
View PDF0 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

After oral administration, allopurinol is completely absorbed in the gastrointestinal tract, and the peak plasma concentration can be reached in 2-6 hours, with a half-life of 1-3 hours. This product is metabolized into active oxypurinol in the liver, with a half-life of 15 hours. -18 hours, the current market is generally conventional tablets, generally need to take 1-2 times a day, and can not maintain a stable and effective blood concentration of anti-gout

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Embodiment 1: This embodiment prepares 1000 allopurinol sustained-release tablets, using the following raw materials:

[0017] Allopurinol 250.0g

[0018] Xylitol 145g

[0019] Starch 50.0g

[0020] Hydroxypropyl Methyl Cellulose 35g

[0021] Povidone 15.0g

[0022] Magnesium Stearate 5.0g

[0023] Process: crush the raw materials and pass through 100 sieves, weigh allopurinol, starch, xylitol and hydroxypropyl methylcellulose according to the prescription amount, and mix them evenly; use 10% povidone alcohol solution to make the mixed materials evenly Soft materials are granulated through a 18-mesh sieve; the wet granules are dried at 55°C to 60°C, granulated through a 18-mesh sieve, and the remaining hydroxypropyl methylcellulose, xylitol, and magnesium stearate are added and mixed; According to the determined tablet weight range, it is obtained by pressing tablets.

[0024] The dissolution rate of the...

Embodiment 2

[0028] Embodiment 2: This embodiment prepares 1000 allopurinol sustained-release tablets, using the following raw materials:

[0029] Allopurinol 250g

[0030] Mannitol 120g

[0031] Starch 75g

[0032] Hypromellose 35g

[0033] Povidone 15g

[0034] Magnesium Stearate 5.0g

[0035] The preparation process is the same as the preparation method of the examples.

Embodiment 3

[0036] Embodiment 3: This embodiment prepares 1000 allopurinol sustained-release tablets, using the following raw materials:

[0037] Allopurinol 250g

[0038] Mannitol 120g

[0039] Starch 90g

[0040] Sodium Alginate 20g

[0041] Povidone 15g

[0042] Magnesium Stearate 5.0g

[0043] The preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to medicine form, and is especially slowly releasing allopurinol tablet and its preparation process. The slowly releasing allopurinol tablet includes allopurinol as main medicine component 10-70 wt%, slowly releasing skeleton matrix 1-15 wt%, soluble diluent 25-85 wt% and adhesive 1-10 wt%. The slowly releasing allopurinol tablet needs to be taken once a day and provides the patient with certain dependence to maintain smooth blood medicine concentration.

Description

technical field [0001] The invention relates to a dosage form of medicine, in particular to an allopurinol sustained-release tablet and a preparation method thereof. Background technique [0002] Allopurinol is a xanthine oxidase inhibitor. By inhibiting the activity of xanthine oxidase, it can reduce the synthesis of uric acid from hypoxanthine and xanthine, and reduce the concentration of uric acid in blood and urine. It has entered the National Essential Drug List and is the first-line drug for the treatment of gout. The United States Pharmacopoeia, European Pharmacopoeia, British Pharmacopoeia, etc. have all been included, and the second volume of the Chinese Pharmacopoeia 2000 edition has also been included. After oral administration, allopurinol is completely absorbed in the gastrointestinal tract, and the peak plasma concentration can be reached in 2-6 hours, with a half-life of 1-3 hours. This product is metabolized into active oxypurinol...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/52A61K9/22A61P19/06
Inventor 范敏华
Owner HAINAN PULIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com